BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11363644)

  • 1. Pneumonia.
    Mirken B
    BETA; 1996 Jun; ():13-8. PubMed ID: 11363644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
    González-García J; Rubio García R; Antela López A; García Alcaide F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of pneumonia related to HIV--pneumocystis carinii pneumonia (PCP)].
    Sidahora; 1995; ():31-2. PubMed ID: 11363204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of Pneumocystis carinii in patients with AIDS receiving chemoprophylaxis.
    Epstein LJ; Meyer RD; Antonson S; Strigle SM; Mohsenifar Z
    Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1456-9. PubMed ID: 7952576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [AIDS complicated by Pneumocystis carinii pneumonia: report of 20 cases].
    Zhao QX; Li XY; He Y; Zhao XL; Ren YJ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):855-6. PubMed ID: 12297457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protect yourself from Pneumocystis carinii.
    AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS.
    Hughes W; Leoung G; Kramer F; Bozzette SA; Safrin S; Frame P; Clumeck N; Masur H; Lancaster D; Chan C
    N Engl J Med; 1993 May; 328(21):1521-7. PubMed ID: 8479489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumocystis carinii pneumonia (PCP) in HIV-infected African children.
    Zar HJ
    SADJ; 2001 Dec; 56(12):617-9. PubMed ID: 11887451
    [No Abstract]   [Full Text] [Related]  

  • 10. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
    Chaisson RE; Keruly J; Richman DD; Moore RD
    Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
    Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
    Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of pneumocystis pneumonia.
    Masur H
    N Engl J Med; 1992 Dec; 327(26):1853-60. PubMed ID: 1448123
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021.
    Hardy WD; Feinberg J; Finkelstein DM; Power ME; He W; Kaczka C; Frame PT; Holmes M; Waskin H; Fass RJ
    N Engl J Med; 1992 Dec; 327(26):1842-8. PubMed ID: 1448121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. Multicenter AIDS Cohort Study.
    Hoover DR; Saah AJ; Bacellar H; Phair J; Detels R; Anderson R; Kaslow RA
    N Engl J Med; 1993 Dec; 329(26):1922-6. PubMed ID: 7902536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole prophylaxis of Pneumocystis carinii pneumonia in infants.
    Mueller BU; Pizzo PA
    Pediatr Infect Dis J; 1992 Dec; 11(12):1072-3. PubMed ID: 1461709
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
    Bender MA; Sax PE
    N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimizing PCP therapy.
    Torres G; Cadman J
    GMHC Treat Issues; 1997 Oct; 11(10):3-5. PubMed ID: 11364821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylaxis and therapy for Pneumocystis pneumonia--where are we?
    Masur H
    Infect Agents Dis; 1992 Oct; 1(5):270-8. PubMed ID: 1344666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection. Grupo de Estudio del SIDA 04/98.
    Lopez Bernaldo de Quiros JC; Miro JM; Peña JM; Podzamczer D; Alberdi JC; Martínez E; Cosin J; Claramonte X; Gonzalez J; Domingo P; Casado JL; Ribera E;
    N Engl J Med; 2001 Jan; 344(3):159-67. PubMed ID: 11172138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.